PFE's digital pharmacy aims to provide patients easy access to its medicines for COVID-19, migraine and other conditions.
Major drugmakers Pfizer and Eli Lilly made major direct-to-consumer announcements. While Walgreens was named as a partner for Pfizer's new direct health platform, it stands to potentially lose out on retail drug sales.
A brand new round of Covid shots from Pfizer and Moderna is about to reach Americans. Meanwhile, CNBC tested out Dexcom's new CGM Stelo.
Pfizer Inc is launching a new website to promote and improve access to its health care offerings for migraine and respiratory illnesses.
Pfizer Inc. on Tuesday unveiled a new online platform designed to help simplify and coordinate healthcare for consumers, adding momentum to an emerging trend in big pharma that has drawn criticism from some provider groups and policy experts.
One of Pfizer's vaccine programs failed to demonstrate its utility. Its competitors had the same issue with their programs.
On Thursday, the FDA cleared new versions of Pfizer's (PFE) and Moderna's (MRNA) COVID-19 vaccines that are designed to match COVID-19 strains currently circulating in the country.
It is never too early to start your investment journey.
US regulators have approved a new series of updated and improved COVID-19 vaccines to target a resurgence of the virus as new strains emerge. Pfizer Inc (NYSE:PFE, ETR:PFE) and Moderna Inc (NASDAQ:MRNA, ETR:0QF) are set to begin shipping immediately while a third US manufacturer, Novavax, expects to start deliveries later.
The Food and Drug Administration on Thursday gave Pfizer Inc. and Moderna Inc. approval for updated COVID-19 vaccines, as a summer wave of the virus is still rolling across the country.
The Food and Drug Administration approved updated Covid vaccines from Pfizer and Moderna, putting the shots on track to reach most Americans in the coming days as the virus surges. The jabs target a strain called KP.2, a descendant of the highly contagious omicron subvariant JN.1 that began circulating widely in the U.S. earlier this year.
24/7 Wall St. Insights Pfizer is one of the highest-yielding S&P 500 stocks.